Pub Date : 2025-09-01Epub Date: 2025-09-19DOI: 10.1055/s-0045-1811726
Diogo Haddad-Santos, Filipi Fim Andreão, Filipe Virgilio Ribeiro, Karlos Daniell Araújo Dos Santos, Fernanda Herculano, Guilherme Sciascia do Olival, Rafael Paterno Dias Carneiro
The present paper explores the extraordinary life of cellist Jacqueline du Pré, her remarkable contribution to music, and her battle with multiple sclerosis (MS). Beyond her artistic impact, we discuss how her story influenced the creation of the Brazilian Multiple Sclerosis Association (Associação Brasileira de Esclerose Múltipla, ABEM, in Portuguese) and its cultural significance in Brazil, particularly through the play Duet for One, by Tom Kempinski. The study reflects on the role of art as a powerful tool to raise awareness and contribute to the understanding of diseases.
本文探讨了大提琴家杰奎琳·杜普莱尔非凡的一生,她对音乐的卓越贡献,以及她与多发性硬化症(MS)的斗争。除了她的艺术影响之外,我们还讨论了她的故事如何影响巴西多发性硬化症协会(associa o Brasileira de Esclerose Múltipla, ABEM,葡萄牙语)的成立,以及该协会在巴西的文化意义,特别是通过汤姆·凯宾斯基的戏剧《一个人的双人舞》。这项研究反映了艺术作为提高认识和促进了解疾病的有力工具的作用。
{"title":"A cello concert in Brazilian lands: the life, art, and disease of Jacqueline du Pré.","authors":"Diogo Haddad-Santos, Filipi Fim Andreão, Filipe Virgilio Ribeiro, Karlos Daniell Araújo Dos Santos, Fernanda Herculano, Guilherme Sciascia do Olival, Rafael Paterno Dias Carneiro","doi":"10.1055/s-0045-1811726","DOIUrl":"10.1055/s-0045-1811726","url":null,"abstract":"<p><p>The present paper explores the extraordinary life of cellist Jacqueline du Pré, her remarkable contribution to music, and her battle with multiple sclerosis (MS). Beyond her artistic impact, we discuss how her story influenced the creation of the Brazilian Multiple Sclerosis Association (Associação Brasileira de Esclerose Múltipla, ABEM, in Portuguese) and its cultural significance in Brazil, particularly through the play <i>Duet for One</i>, by Tom Kempinski. The study reflects on the role of art as a powerful tool to raise awareness and contribute to the understanding of diseases.</p>","PeriodicalId":8694,"journal":{"name":"Arquivos de neuro-psiquiatria","volume":"83 9","pages":"1-3"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12449094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145091183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-09-19DOI: 10.1055/s-0045-1811727
Mario Manto, Hiroshi Mitoma
Cerebellar syndrome is traditionally categorized into three primary types: cerebellar motor syndrome (CMS), vestibulocerebellar syndrome (VCS), and cerebellar cognitive affective syndrome (CCAS) or Schmahmann syndrome (SS). The first type is subdivided into five elemental features: dysmetria, kinetic tremor, asynergia, adiadochokinesis and dyschronometria. The second is characterized by dysmetria of saccades and jerky pursuit, as well as downbeat nystagmus and gaze-evoked nystagmus. And the third type is associated with a broader spectrum of cognitive and affective symptoms, including impairments in executive function, spatial cognition, language processing and emotional regulation. In its extreme form, cerebellar mutism can also develop during childhood following cerebellar vermis surgery. Recent physiological studies have shed light on the underlying neural mechanisms of these syndromes by identifying a common link of dysfunction within the cerebellum's internal forward model. This is essential to the prediction of the outcomes of motor and cognitive actions and underlines dysmetria as the core common element. Despite the diversity in clinical presentation, cerebellar syndromes can be understood as disruptions of a unified neural mechanism, providing a new framework for better understanding of cerebellar deficits.
{"title":"Cerebellar syndromes: clinical observations leading to the recognition of the three types.","authors":"Mario Manto, Hiroshi Mitoma","doi":"10.1055/s-0045-1811727","DOIUrl":"10.1055/s-0045-1811727","url":null,"abstract":"<p><p>Cerebellar syndrome is traditionally categorized into three primary types: cerebellar motor syndrome (CMS), vestibulocerebellar syndrome (VCS), and cerebellar cognitive affective syndrome (CCAS) or Schmahmann syndrome (SS). The first type is subdivided into five elemental features: dysmetria, kinetic tremor, asynergia, adiadochokinesis and dyschronometria. The second is characterized by dysmetria of saccades and jerky pursuit, as well as downbeat nystagmus and gaze-evoked nystagmus. And the third type is associated with a broader spectrum of cognitive and affective symptoms, including impairments in executive function, spatial cognition, language processing and emotional regulation. In its extreme form, cerebellar mutism can also develop during childhood following cerebellar vermis surgery. Recent physiological studies have shed light on the underlying neural mechanisms of these syndromes by identifying a common link of dysfunction within the cerebellum's internal forward model. This is essential to the prediction of the outcomes of motor and cognitive actions and underlines dysmetria as the core common element. Despite the diversity in clinical presentation, cerebellar syndromes can be understood as disruptions of a unified neural mechanism, providing a new framework for better understanding of cerebellar deficits.</p>","PeriodicalId":8694,"journal":{"name":"Arquivos de neuro-psiquiatria","volume":"83 9","pages":"1-8"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12449102/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145091149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-10-31DOI: 10.1055/s-0045-1811721
Gloria M A S Tedrus, Danilo Wingeter Ramalho, Elisa Dal Rio Teixeira
Epilepsy is a condition that can lead to social difficulties and restrictions.To evaluate social and occupational functioning and relationships with clinical findings of Brazilian adult patients with epilepsy.The scores of the Social and Occupational Functioning Scale for Epilepsy (SOFSE) were related to the clinical data of adult patients with epilepsy.Among the 79 cases included, with a mean age of 44.3 years old, 47 were employed and 32 were unemployed. It was observed that there was a predominance of males among the employed patients (32 [68.1%] versus 15 [31.9]; p = 0.008), most patients had a companion (27 [57.4%] versus 20 [42.6%]; p = 0.005), and most patients had no anxiety symptoms on the Hospital Anxiety and Depression Scale (HADS) (30 [63.8%] versus 17 [36.2%]; p = 0.011). The total score in the SOFSE was 64.7, with a higher total score among the employed patients (56.6 ± 12.5 versus 70.3 ± 14.3; p < 0.001). There was a correlation between the total SOFSE score with formal education (r = 0.30) and with HADS-anxiety (r = - 0.56) and HADS-depression (r = - 0.36). Lower scores in the communication domain were associated with a high frequency of seizures. There were lower scores in the domain leisure activity in TLE (2.0 ± 2.0 versus. 2.2 ± 1.5; p = 0.014).The unemployment rate was high in adults with epilepsy. Employment was associated with male gender, having a companion, and absence of anxiety symptoms. Better functional adjustment was associated with schooling. Social and occupational functional impairment was associated with a high frequency of seizures, TLE, and anxious and depressive symptoms.
{"title":"Social and occupational functioning scale for epilepsy: performance in Brazilian adult patients with epilepsy.","authors":"Gloria M A S Tedrus, Danilo Wingeter Ramalho, Elisa Dal Rio Teixeira","doi":"10.1055/s-0045-1811721","DOIUrl":"10.1055/s-0045-1811721","url":null,"abstract":"<p><p>Epilepsy is a condition that can lead to social difficulties and restrictions.To evaluate social and occupational functioning and relationships with clinical findings of Brazilian adult patients with epilepsy.The scores of the Social and Occupational Functioning Scale for Epilepsy (SOFSE) were related to the clinical data of adult patients with epilepsy.Among the 79 cases included, with a mean age of 44.3 years old, 47 were employed and 32 were unemployed. It was observed that there was a predominance of males among the employed patients (32 [68.1%] versus 15 [31.9]; <i>p</i> = 0.008), most patients had a companion (27 [57.4%] versus 20 [42.6%]; <i>p</i> = 0.005), and most patients had no anxiety symptoms on the Hospital Anxiety and Depression Scale (HADS) (30 [63.8%] versus 17 [36.2%]; <i>p</i> = 0.011). The total score in the SOFSE was 64.7, with a higher total score among the employed patients (56.6 ± 12.5 versus 70.3 ± 14.3; <i>p</i> < 0.001). There was a correlation between the total SOFSE score with formal education (r = 0.30) and with HADS-anxiety (r = - 0.56) and HADS-depression (r = - 0.36). Lower scores in the communication domain were associated with a high frequency of seizures. There were lower scores in the domain leisure activity in TLE (2.0 ± 2.0 versus. 2.2 ± 1.5; <i>p</i> = 0.014).The unemployment rate was high in adults with epilepsy. Employment was associated with male gender, having a companion, and absence of anxiety symptoms. Better functional adjustment was associated with schooling. Social and occupational functional impairment was associated with a high frequency of seizures, TLE, and anxious and depressive symptoms.</p>","PeriodicalId":8694,"journal":{"name":"Arquivos de neuro-psiquiatria","volume":"83 9","pages":"1-7"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12578575/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145421156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-10-27DOI: 10.1055/s-0045-1811720
Renata Andrade, Wilson Marques Junior, Luiza Vasconcelos, Paula Pungartnik, Thaís Zamboni Berra, Lucas Vieira Cortez, Daiane Beneduzzi
Myasthenia gravis (MG) is a rare neurological disease and the most common autoimmune disorder, characterized by muscle weakness. In Brazil, there is limited data on these patients within the Brazilian public healthcare system (SUS, from Sistema Único de Saúde, in Portuguese).To assess patients with MG in the Brazilian public healthcare system to understand their characteristics, patient journey, and treatment patterns.A retrospective observational study using real-world data from SUS to analyze patients with MG from January 2010 to December 2023. Data were extracted from the DATASUS, focusing on the Outpatient Procedure (SIA) and Hospital Admissions (SIH) information systems. Probabilistic record linkage compiled longitudinal patient data, assessing epidemiology, demographics, clinical characteristics, and treatment patterns, including medications, doses, and lines of treatment (LOT).A total of 13,476 patients with MG were identified. Admissions in healthcare units increased over the years, with 30.4% experiencing exacerbations and 9% crises. The mean age was 45.6 years, with a majority being female (65.4%) and white (53.4%). The case-fatality rate rose from 0.76% in 2011 to 1.90% in 2023. Treatment patterns showed frequent transitions between LOT, indicating constant instability and inadequate symptom control, with azathioprine and pyridostigmine being the most used medications. Some patients started treatment with intravenous immunoglobulin (IVIg), used in combination with other medications, and continued it continuously.The study highlights the increasing burden of MG on SUS, emphasizing the challenges of disease management and the need for continuous advancements in diagnostic and therapeutic strategies to improve patient outcomes.
重症肌无力(MG)是一种罕见的神经系统疾病和最常见的自身免疫性疾病,其特征是肌肉无力。在巴西,巴西公共卫生系统(SUS,来自Sistema Único de Saúde,葡萄牙语)中关于这些患者的数据有限。评估巴西公共医疗保健系统中MG患者,了解他们的特点、患者旅程和治疗模式。一项回顾性观察性研究,使用SUS的真实数据分析2010年1月至2023年12月MG患者。数据从DATASUS中提取,重点是门诊程序(SIA)和住院(SIH)信息系统。概率记录链接汇编了纵向患者数据,评估流行病学、人口统计学、临床特征和治疗模式,包括药物、剂量和治疗线(LOT)。共有13476例MG患者被确定。多年来,到医疗机构就诊的人数有所增加,其中30.4%出现病情恶化,9%出现危机。平均年龄45.6岁,以女性(65.4%)和白人(53.4%)居多。病死率从2011年的0.76%上升到2023年的1.90%。治疗模式显示LOT之间的频繁转换,表明持续不稳定和症状控制不足,其中硫唑嘌呤和吡哆斯的明是最常用的药物。一些患者开始使用静脉注射免疫球蛋白(IVIg)治疗,与其他药物联合使用,并持续使用。该研究强调了MG对SUS的负担日益增加,强调了疾病管理的挑战以及不断改进诊断和治疗策略以改善患者预后的必要性。
{"title":"Patient journey and treatment pattern in myasthenia gravis: real-world data from the Brazilian public health system.","authors":"Renata Andrade, Wilson Marques Junior, Luiza Vasconcelos, Paula Pungartnik, Thaís Zamboni Berra, Lucas Vieira Cortez, Daiane Beneduzzi","doi":"10.1055/s-0045-1811720","DOIUrl":"10.1055/s-0045-1811720","url":null,"abstract":"<p><p>Myasthenia gravis (MG) is a rare neurological disease and the most common autoimmune disorder, characterized by muscle weakness. In Brazil, there is limited data on these patients within the Brazilian public healthcare system (SUS, from Sistema Único de Saúde, in Portuguese).To assess patients with MG in the Brazilian public healthcare system to understand their characteristics, patient journey, and treatment patterns.A retrospective observational study using real-world data from SUS to analyze patients with MG from January 2010 to December 2023. Data were extracted from the DATASUS, focusing on the Outpatient Procedure (SIA) and Hospital Admissions (SIH) information systems. Probabilistic record linkage compiled longitudinal patient data, assessing epidemiology, demographics, clinical characteristics, and treatment patterns, including medications, doses, and lines of treatment (LOT).A total of 13,476 patients with MG were identified. Admissions in healthcare units increased over the years, with 30.4% experiencing exacerbations and 9% crises. The mean age was 45.6 years, with a majority being female (65.4%) and white (53.4%). The case-fatality rate rose from 0.76% in 2011 to 1.90% in 2023. Treatment patterns showed frequent transitions between LOT, indicating constant instability and inadequate symptom control, with azathioprine and pyridostigmine being the most used medications. Some patients started treatment with intravenous immunoglobulin (IVIg), used in combination with other medications, and continued it continuously.The study highlights the increasing burden of MG on SUS, emphasizing the challenges of disease management and the need for continuous advancements in diagnostic and therapeutic strategies to improve patient outcomes.</p>","PeriodicalId":8694,"journal":{"name":"Arquivos de neuro-psiquiatria","volume":"83 9","pages":"1-10"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558700/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145375886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2026-01-28DOI: 10.1055/s-0045-1806832
Partiksha, Sakshi Sadhu
{"title":"The effect of proprioceptive vestibular rehabilitation on sensory-motor symptoms and quality of life.","authors":"Partiksha, Sakshi Sadhu","doi":"10.1055/s-0045-1806832","DOIUrl":"10.1055/s-0045-1806832","url":null,"abstract":"","PeriodicalId":8694,"journal":{"name":"Arquivos de neuro-psiquiatria","volume":"83 9","pages":"1"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12851825/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146091908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-09-08DOI: 10.1055/s-0045-1811625
Cecília Fusco Agostinho, Glória M A S Tedrus
Symptoms in the postictal period are often neglected by professionals and patients/family members.To relate the characteristics of the postictal period with the clinical variables of adult patients with epilepsy.Prospectively, the clinical characteristics of the postictal period were related to the clinical variables and the scores on the Hospital Anxiety and Depression Scale (HADS) and Mini-Mental State Examination (MMSE) of 70 patients with epilepsy.The mean age was 47.6 years old, and 34 (48.6%) patients were male, the mean age at onset of epilepsy was 20.3 years old, the epileptic syndrome was structural in 48 cases, the mean score in the MMSE was 23.6, the mean score in the HADS-anxiety was 7.3, and in the HADS-depression it was 5.6. Postictal manifestation occurred in 59 (84.2%) cases, with prolonged duration in 22 (37.2%) cases. There was a difference in the duration and presence of postictal manifestation according to age at the onset of epilepsy. Higher HADS-anxiety scores were associated with the presence of confusion in the postictal period (t-test; 9.3 ± 6.8 versus 5.8 ± 4.8; p = 0.015). Lower MMSE scores were related to postictal anxiety and sleepiness/headache/confusion. Left-sided epileptiform activity (EA) was associated with postictal sleepiness/headache/confusion. There was a difference in postictal manifestation according to epileptic syndrome.The characteristics of the postictal period differed according to the age of onset, the type of seizure, and the epileptic syndrome. Different symptoms in the postictal period were associated with the scores on HADS anxiety, MMSE, and left-sided EA on the electroencephalogram.
{"title":"Postictal status and clinical variables in adults with epilepsy.","authors":"Cecília Fusco Agostinho, Glória M A S Tedrus","doi":"10.1055/s-0045-1811625","DOIUrl":"10.1055/s-0045-1811625","url":null,"abstract":"<p><p>Symptoms in the postictal period are often neglected by professionals and patients/family members.To relate the characteristics of the postictal period with the clinical variables of adult patients with epilepsy.Prospectively, the clinical characteristics of the postictal period were related to the clinical variables and the scores on the Hospital Anxiety and Depression Scale (HADS) and Mini-Mental State Examination (MMSE) of 70 patients with epilepsy.The mean age was 47.6 years old, and 34 (48.6%) patients were male, the mean age at onset of epilepsy was 20.3 years old, the epileptic syndrome was structural in 48 cases, the mean score in the MMSE was 23.6, the mean score in the HADS-anxiety was 7.3, and in the HADS-depression it was 5.6. Postictal manifestation occurred in 59 (84.2%) cases, with prolonged duration in 22 (37.2%) cases. There was a difference in the duration and presence of postictal manifestation according to age at the onset of epilepsy. Higher HADS-anxiety scores were associated with the presence of confusion in the postictal period (t-test; 9.3 ± 6.8 versus 5.8 ± 4.8; <i>p =</i> 0.015). Lower MMSE scores were related to postictal anxiety and sleepiness/headache/confusion. Left-sided epileptiform activity (EA) was associated with postictal sleepiness/headache/confusion. There was a difference in postictal manifestation according to epileptic syndrome.The characteristics of the postictal period differed according to the age of onset, the type of seizure, and the epileptic syndrome. Different symptoms in the postictal period were associated with the scores on HADS anxiety, MMSE, and left-sided EA on the electroencephalogram.</p>","PeriodicalId":8694,"journal":{"name":"Arquivos de neuro-psiquiatria","volume":"83 9","pages":"1-6"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12417039/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145022784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-06-21DOI: 10.1055/s-0045-1809403
Lídia Laura Salvador Ramos, Iago Resende Carvalho, Diogo Fernandes Dos Santos, Andrea de Martino Luppi, Bruno de Carvalho Dornelas
{"title":"Erdheim-Chester manifesting purely as a neurological disease.","authors":"Lídia Laura Salvador Ramos, Iago Resende Carvalho, Diogo Fernandes Dos Santos, Andrea de Martino Luppi, Bruno de Carvalho Dornelas","doi":"10.1055/s-0045-1809403","DOIUrl":"10.1055/s-0045-1809403","url":null,"abstract":"","PeriodicalId":8694,"journal":{"name":"Arquivos de neuro-psiquiatria","volume":"83 9","pages":"1-2"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12182407/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144339875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-09-19DOI: 10.1055/s-0045-1811722
Elif Simin Issi
Small fiber neuropathy (SFN) affects thinly myelinated and unmyelinated fibers, often presenting with subtle clinical signs that are undetectable in routine nerve conduction studies. Vitamin B12 deficiency is a known risk factor for SFN, yet early-stage cases frequently remain undiagnosed. Sympathetic skin response (SSR) and cutaneous silent period (CSP) are noninvasive electrophysiological techniques used to assess autonomic and somatic small fiber function.The present study aimed to evaluate the diagnostic utility of SSR and CSP in detecting possible subclinical small-fiber neuropathy (pSFN) in individuals with early-stage vitamin B12 deficiency.The present observational study included 28 patients with vitamin B12 deficiency who had nonspecific complaints, Douleur Neuropathique en 4 Questions (DN4) scores < 4, and normal nerve conduction studies, along with 25 healthy controls. Electrophysiological testing involved SSR recordings from all extremities and CSP measurements from the right median and sural nerves.In the patient group, Median Nerve Cutaneous Silent Period (MN-CSP) and Tibialis Anterior -Sural Cutaneous Silent Period (TA-sural CSP) durations were significantly shorter, while termination and onset latencies were prolonged compared with controls. MN-CSP and TA-sural CSP durations demonstrated high diagnostic accuracy. Sympathetic skin response latencies were significantly prolonged in both hands and feet, indicating autonomic dysfunction. No significant differences were observed in SSR amplitudes.Sympathetic skin response and CSP are valuable tools for detecting possible subclinical SFN in vitamin B12 deficiency. Sympathetic skin response effectively identified autonomic dysfunction, while CSP provided additional diagnostic value for somatic small fiber impairment. Combining SSR and CSP may enhance early detection of pSFN in vitamin B12 deficiency and allow timely intervention.
{"title":"Assessment of possible small fiber Neuropathy in early-stage vitamin B12 deficiency using electrophysiological methods.","authors":"Elif Simin Issi","doi":"10.1055/s-0045-1811722","DOIUrl":"10.1055/s-0045-1811722","url":null,"abstract":"<p><p>Small fiber neuropathy (SFN) affects thinly myelinated and unmyelinated fibers, often presenting with subtle clinical signs that are undetectable in routine nerve conduction studies. Vitamin B12 deficiency is a known risk factor for SFN, yet early-stage cases frequently remain undiagnosed. Sympathetic skin response (SSR) and cutaneous silent period (CSP) are noninvasive electrophysiological techniques used to assess autonomic and somatic small fiber function.The present study aimed to evaluate the diagnostic utility of SSR and CSP in detecting possible subclinical small-fiber neuropathy (pSFN) in individuals with early-stage vitamin B12 deficiency.The present observational study included 28 patients with vitamin B12 deficiency who had nonspecific complaints, Douleur Neuropathique en 4 Questions (DN4) scores < 4, and normal nerve conduction studies, along with 25 healthy controls. Electrophysiological testing involved SSR recordings from all extremities and CSP measurements from the right median and sural nerves.In the patient group, Median Nerve Cutaneous Silent Period (MN-CSP) and Tibialis Anterior -Sural Cutaneous Silent Period (TA-sural CSP) durations were significantly shorter, while termination and onset latencies were prolonged compared with controls. MN-CSP and TA-sural CSP durations demonstrated high diagnostic accuracy. Sympathetic skin response latencies were significantly prolonged in both hands and feet, indicating autonomic dysfunction. No significant differences were observed in SSR amplitudes.Sympathetic skin response and CSP are valuable tools for detecting possible subclinical SFN in vitamin B12 deficiency. Sympathetic skin response effectively identified autonomic dysfunction, while CSP provided additional diagnostic value for somatic small fiber impairment. Combining SSR and CSP may enhance early detection of pSFN in vitamin B12 deficiency and allow timely intervention.</p>","PeriodicalId":8694,"journal":{"name":"Arquivos de neuro-psiquiatria","volume":"83 9","pages":"1-7"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12449103/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145091133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-07-28DOI: 10.1055/s-0045-1809332
Pedro Augusto Sampaio Rocha-Filho
Medication-overuse headache affects 1 to 2% of the global population and is often associated with chronic migraine. This condition significantly impacts the lives of patients, as well as their families, and it poses a major economic burden due to lost productivity and medical costs. The present narrative review is part of a controversy session. We argue that reversing the behavior of overusing symptomatic pain medications is important for the treatment of this type of headache. To support this argument, the article reviews and critically analyzes the relevant literature on the subject.
{"title":"Calcitonin gene-related peptide monoclonal antibodies and medication-overuse headache: stopping excessive pain medication is still necessary.","authors":"Pedro Augusto Sampaio Rocha-Filho","doi":"10.1055/s-0045-1809332","DOIUrl":"10.1055/s-0045-1809332","url":null,"abstract":"<p><p>Medication-overuse headache affects 1 to 2% of the global population and is often associated with chronic migraine. This condition significantly impacts the lives of patients, as well as their families, and it poses a major economic burden due to lost productivity and medical costs. The present narrative review is part of a controversy session. We argue that reversing the behavior of overusing symptomatic pain medications is important for the treatment of this type of headache. To support this argument, the article reviews and critically analyzes the relevant literature on the subject.</p>","PeriodicalId":8694,"journal":{"name":"Arquivos de neuro-psiquiatria","volume":"83 9","pages":"1-4"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12303620/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144726972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}